Immune globulin 10% (Kedrion)

N/A

Report date: 2026/04/28 20:00:22

Base Information

Drug NameImmune globulin 10% (Kedrion)
Drug Alias NameQIVIGY
ClassificationBiologics > Blood components
Mechanisms of ActionImmunoglobulin G IgG replacement
TargetsImmunoglobulin G
Therapy Area/IndicationsImmunologic Deficiency SyndromesPrimary Immunodeficiency DiseasesAgammaglobulinemia +[6] 
Global Approved IndicationsPrimary Immunodeficiency Diseases
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2025/09/26
Country/TerritoryCzechiaCanadaUnited States +[12] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesKedrion Spa
China Registration ClassN/A

Develop Information

Active CompaniesKedrion Spa
Inactive CompaniesN/A
Active IndicationsPrimary Immunodeficiency DiseasesPurpura, Thrombocytopenic, IdiopathicStiff-Person Syndrome +[4] 
Inactive IndicationsImmunologic Deficiency SyndromesAgammaglobulinemia

Other Information

ATC CodeN/A
Related LinksN/A